Photo from wikipedia
The Bacillus Calmette–Guérin (BCG) vaccine may confer cross‐protection against viral diseases in adults. This study evaluated BCG vaccine cross‐protection in adults with convalescent coronavirus disease 2019 (COVID‐19). Click to show full abstract
The Bacillus Calmette–Guérin (BCG) vaccine may confer cross‐protection against viral diseases in adults. This study evaluated BCG vaccine cross‐protection in adults with convalescent coronavirus disease 2019 (COVID‐19).
Keywords:
randomized clinical;
bcg vaccine;
bcg;
clinical trial;
trial bcg
Journal Title: Journal of Internal Medicine
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Internal Medicine
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!